Radiation metabolomics: Current status and future directions

Frontiers in Oncology

Volumn 6, Issue FEB, 2016, Pages

  Menon, Smrithi S ^a   Uppal, Medha ^a   Randhawa, Subeena ^a   Cheema, Mehar S ^a   Aghdam, Nima ^b   Usala, Rachel L ^c   Ghosh, Sanchita P ^d   Cheema, Amrita K ^a   Dritschilo, Anatoly ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d ARMED FORCES RADIOBIOLOGY RESEARCH INSTITUTE   (United States)

Author keywords

Biomarkers; Ionizing radiation; Metabolomics

Indexed keywords

ALANINE; BETAINE; CHECKPOINT KINASE 1; CHECKPOINT KINASE 2; CHOLINE; CITRULLINE; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; DEOXYURIDINE; GLUTAMIC ACID; HISTONE H2AX; INDUCIBLE NITRIC OXIDE SYNTHASE; ISOLEUCINE; LACTIC ACID; LEUCINE; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLCHOLINE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TAURINE; THYMIDINE; VALINE; XANTHINE; XANTHOSINE;

APOPTOSIS; CELL CYCLE ARREST; CHEMORADIOTHERAPY; CHROMATOGRAPHY; DISEASE COURSE; DNA DAMAGE; DOSIMETRY; HUMAN; IONIZING RADIATION; MASS SPECTROMETRY; METABOLOMICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTON THERAPY; RADIATION DOSE; RADIATION EXPOSURE; RADIATION HAZARD; RADIOSENSITIVITY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION;

EID: 84964414688     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2016.00037     Document Type: Review

References (80)

1. Orth M, Lauber K, Niyazi M, Friedl AA, Li M, Maihöfer C, et al. Current concepts in clinical radiation oncology. Radiat Environ Biophys (2014) 53(1):1-29. doi: 10.1007/s00411-013-0497-2
2. Wallner PE, Anscher MS, Barker CA, Bassetti M, Bristow RG, Cha YI, et al. Current status and recommendations for the future of research, teaching, and testing in the biological sciences of radiation oncology: report of the American Society for Radiation Oncology Cancer Biology/Radiation Biology Task Force, executive summary. Int J Radiat Oncol Biol Phys (2014) 88(1):11-7. doi:10.1016/j.ijrobp.2013.09.040
3. United States Nuclear Regulatory Commission. Sources of Radiation. United States Nuclear Regulatory Commission (2014). Available from: http://www.nrc.gov/about-nrc/radiation/around-us/sources.html
4. Rhee EP, Gerszten RE. Metabolomics and cardiovascular biomarker discovery. Clin Chem (2012) 58(1):139-47. doi:10.1373/clinchem.2011.169573
5. Senn T, Hazen SL, Tang WHW. Translating metabolomics to cardiovascular biomarkers. Prog Cardiovasc Dis (2012) 55(1):70-6. doi:10.1016/j.pcad.2012.06.004
6. Salek RM, Maguire ML, Bentley E, Rubtsov DV, Hough T, Cheeseman M, et al. A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human. Physiol Genomics (2007) 29(2):99-108. doi:10.1152/physiolgenomics.00194.2006
7. Patti GJ, Yanes O, Siuzdak G. Innovation: metabolomics: the apogee of the omics trilogy. Nat Rev Mol Cell Biol (2012) 13(4):263-9. doi:10.1038/nrm3314
8. Johnson CH, Gonzalez FJ. Challenges and opportunities of metabolomics. J Cell Physiol (2012) 227(8):2975-81. doi:10.1002/jcp.24002
9. Putri SP, Yamamoto S, Tsugawa H, Fukusaki E. Current metabolomics: technological advances. J Biosci Bioeng (2013) 116(1):9-16. doi:10.1016/j.jbiosc.2013.01.004
10. Rochfort S. Metabolomics reviewed: a new "omics" platform technology for systems biology and implications for natural products research. J Nat Prod (2005) 68(12):1813-20. doi:10.1021/np050255w
11. Zhang AH, Sun H, Qiu S, Wang XJ. NMR-based metabolomics coupled with pattern recognition methods in biomarker discovery and disease diagnosis. Magn Reson Chem (2013) 51(9):549-56. doi:10.1002/mrc.3985
12. Xu J, Zhang J, Cai S, Dong J, Yang JY, Chen Z. Metabonomics studies of intact hepatic and renal cortical tissues from diabetic db/db mice using high-resolution magic-angle spinning 1H NMR spectroscopy. Anal Bioanal Chem (2009) 393(6-7):1657-68. doi:10.1007/s00216-009-2623-1
13. Ross B, Tran T, Bhattacharya P, Martin Watterson D, Sailasuta N. Application of NMR spectroscopy in medicinal chemistry and drug discovery. Curr Top Med Chem (2011) 11(1):93-114. doi:10.2174/156802611793611850
14. Sandusky P, Appiah-Amponsah E, Raftery D. Use of optimized 1D TOCSY NMR for improved quantitation and metabolomic analysis of biofluids. J Biomol NMR (2011) 49(3-4):281-90. doi:10.1007/s10858-011-9483-7
15. Di Girolamo F, Lante I, Muraca M, Putignani L. The role of mass spectrometry in the "omics" era. Curr Org Chem (2013) 17(23):2891-905. doi:10.2174/1385272817888131118162725
16. Boccard J, Veuthey J-L, Rudaz S. Knowledge discovery in metabolomics: an overview of MS data handling. J Sep Sci (2010) 33(3):290-304. doi:10.1002/jssc.200900609
17. Katajamaa M, Oresic M. Data processing for mass spectrometry-based metabolomics. J Chromatogr A (2007) 1158(1-2):318-28. doi:10.1016/j.chroma.2007.04.021
18. Smolinska A, Blanchet L, Buydens LM, Wijmenga SS. NMR and pattern recognition methods in metabolomics: from data acquisition to biomarker discovery: a review. Anal Chim Acta (2012) 750:82-97. doi:10.1016/j.aca.2012.05.049
19. Zhang S, Nagana Gowda GA, Ye T, Raftery D. Advances in NMR-based biofluid analysis and metabolite profiling. Analyst (2010) 135(7):1490-8. doi:10.1039/c000091d
20. Chiu SM, Xue LY, Friedman LR, Oleinick NL. Copper ion-mediated sensitization of nuclear matrix attachment sites to ionizing radiation. Biochemistry (1993) 32(24):6214-9. doi:10.1021/bi00075a014
21. Darley-Usmar VM, Hogg N, O'Leary VJ, Wilson MT, Moncada S. The simultaneous generation of superoxide and nitric oxide can initiate lipid peroxidation in human low density lipoprotein. Free Radic Res Commun (1992) 17(1):9-20. doi:10.3109/10715769209061085
22. Singh A, Singh H. Time-scale and nature of radiation-biological damage: approaches to radiation protection and post-irradiation therapy. Prog Biophys Mol Biol (1982) 39(2):69-107. doi:10.1016/0079-6107(83)90014-7
23. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A (1990) 87(4):1620-4. doi:10.1073/pnas.87.4.1620
24. Blough NV, Zafiriou OC. Reaction of superoxide with nitric oxide to form peroxonitrite in alkaline aqueous solution. Inorg Chem (1985) 04:3502-4. doi:10.1021/ic00216a003
25. Barglow KT, Cravatt BF. Activity-based protein profiling for the functional annotation of enzymes. Nat Methods (2007) 4(10):822-7. doi:10.1038/nmeth1092
26. Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Egido J. Inflammation and angiotensin II. Int J Biochem Cell Biol (2003) 35(6):881-900. doi:10.1016/S1357-2725(02)00271-6
27. Reisz JA, Bansal N, Qian J, Zhao W, Furdui CM. Effects of ionizing radiation on biological molecules-mechanisms of damage and emerging methods of detection. Antioxid Redox Signal (2014) 21(2):260-92. doi:10.1089/ars.2013.5489
28. Houee-Levin C, Bobrowski K. The use of the methods of radiolysis to explore the mechanisms of free radical modifications in proteins. J Proteomics (2013) 92:51-62. doi:10.1016/j.jprot.2013.02.014
29. Reiter RJ, Korkmaz A, Ma S, Rosales-Corral S, Tan DX. Melatonin protection from chronic, low-level ionizing radiation. Mutat Res (2012) 751(1):7-14. doi:10.1016/j.mrrev.2011.12.002
30. Sram RJ, Binkova B, Rossner P. Vitamin C for DNA damage prevention. Mutat Res (2012) 733(1-2):39-49. doi:10.1016/j.mrfmmm.2011.12.001
31. Tan DX, Manchester LC, Terron MP, Flores LJ, Reiter RJ. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res (2007) 42(1):28-42. doi:10.1111/j.1600-079X.2006.00407.x
32. Traber MG, Atkinson J. Vitamin E, antioxidant and nothing more. Free Radic Biol Med (2007) 43(1):4-15. doi:10.1016/j.freeradbiomed.2007.03.024
33. Laiakis EC, Strassburg K, Bogumil R, Lai S, Vreeken RJ, Hankemeier T, et al. Metabolic phenotyping reveals a lipid mediator response to ionizing radiation. J Proteome Res (2014) 13(9):4143-54. doi:10.1021/pr5005295
34. Roos WP, Kaina B. DNA damage-induced cell death: from specific DNA lesions to the DNA damage response and apoptosis. Cancer Lett (2013) 332(2):237-48. doi:10.1016/j.canlet.2012.01.007
35. Zannella VE, Cojocari D, Hilgendorf S, Vellanki RN, Chung S, Wouters BG, et al. AMPK regulates metabolism and survival in response to ionizing radiation. Radiother Oncol (2011) 99(3):293-9. doi:10.1016/j.radonc.2011.05.049
36. Katsube T, Mori M, Tsuji H, Shiomi T, Wang B, Liu Q, et al. Most hydrogen peroxide-induced histone H2AX phosphorylation is mediated by ATR and is not dependent on DNA double-strand breaks. J Biochem (2014) 156(2):85-95. doi:10.1093/jb/mvu021
37. Dieriks B, De Vos W, Baatout S, Van Oostveldt P. Repeated exposure of human fibroblasts to ionizing radiation reveals an adaptive response that is not mediated by interleukin-6 or TGF-β. Mutat Res (2011) 715(1-2):19-24. doi:10.1016/j.mrfmmm.2011.07.002
38. Fritz KS, Petersen DR. Exploring the biology of lipid peroxidation-derived protein carbonylation. Chem Res Toxicol (2011) 24(9):1411-9. doi:10.1021/tx200169n
39. Girotti AW. Lipid hydroperoxide generation, turnover, and effector action in biological systems. J Lipid Res (1998) 39(8):1529-42
40. Vit J-P, Rosselli F. Role of the ceramide-signaling pathways in ionizing radiation-induced apoptosis. Oncogene (2003) 22(54):8645-52. doi:10.1038/sj.onc.1207087
41. Maisonneuve E, Ducret A, Khoueiry P, Lignon S, Longhi S, Talla E, et al. Rules governing selective protein carbonylation. PLoS One (2009) 4(10):e7269. doi:10.1371/journal.pone.0007269
42. Uchida K, Stadtman ER. Modification of histidine residues in proteins by reaction with 4-hydroxynonenal. Proc Natl Acad Sci U S A (1992) 89(10):4544-8. doi:10.1073/pnas.89.10.4544
43. Schulz-Ertner D, Tsujii H. Particle radiation therapy using proton and heavier ion beams. J Clin Oncol (2007) 25(8):953-64. doi:10.1200/JCO.2006.09.7816
44. Patterson AD, Li H, Eichler GS, Krausz KW, Weinstein JN, Fornace AJ Jr, et al. UPLC-ESI-TOFMS-based metabolomics and gene expression dynamics inspector self-organizing metabolomic maps as tools for understanding the cellular response to ionizing radiation. Anal Chem (2008) 80(3):665-74. doi:10.1021/ac701807v
45. Varghese RS, Cheema A, Cheema P, Bourbeau M, Tuli L, Zhou B, et al. Analysis of LC-MS data for characterizing the metabolic changes in response to radiation. J Proteome Res (2010) 9(5):2786-93. doi:10.1021/pr100185b
46. Lee R, Britz-McKibbin P. Metabolomic studies of radiation-induced apoptosis of human leukocytes by capillary electrophoresis-mass spectrometry and flow cytometry: adaptive cellular responses to ionizing radiation. Electrophoresis (2010) 31(14):2328-37. doi:10.1002/elps.200900451
47. Li HH, Wang YW, Chen R, Zhou B, Ashwell JD, Fornace AJ Jr. Ionizing radiation impairs T cell activation by affecting metabolic reprogramming. Int J Biol Sci (2015) 11(7):726-36. doi:10.7150/ijbs.12009
48. Hu ZP, Kim YM, Sowa MB, Robinson RJ, Gao X, Metz TO, et al. Metabolomic response of human skin tissue to low dose ionizing radiation. Mol Biosyst (2012) 8(7):1979-86. doi:10.1039/c2mb25061f
49. Tyburski JB, Patterson AD, Krausz KW, Slavík J, Fornace AJ Jr, Gonzalez FJ, et al. Radiation metabolomics. 1. Identification of minimally invasive urine biomarkers for gamma-radiation exposure in mice. Radiat Res (2008) 170(1):1-14. doi:10.1667/RR1265.1
50. Tyburski JB, Patterson AD, Krausz KW, Slavík J, Fornace AJ Jr, Gonzalez FJ, et al. Radiation metabolomics. 2. Dose-and time-dependent urinary excretion of deaminated purines and pyrimidines after sublethal gamma-radiation exposure in mice. Radiat Res (2009) 172(1):42-57. doi:10.1667/RR1703.1
51. Liu H, Wang Z, Zhang X, Qiao Y, Wu S, Dong F, et al. Selection of candidate radiation biomarkers in the serum of rats exposed to gamma-rays by GC/TOFMS-based metabolomics. Radiat Prot Dosimetry (2013) 154(1):9-17. doi:10.1093/rpd/ncs138
52. Manna SK, Krausz KW, Bonzo JA, Idle JR, Gonzalez FJ. Metabolomics reveals aging-associated attenuation of noninvasive radiation biomarkers in mice: potential role of polyamine catabolism and incoherent DNA damage-repair. J Proteome Res (2013) 12(5):2269-81. doi:10.1021/pr400161k
53. Riecke A, Ruf CG, Meineke V. Assessment of radiation damage-the need for a multiparametric and integrative approach with the help of both clinical and biological dosimetry. Health Phys (2010) 98(2):160-7. doi:10.1097/HP.0b013e3181b97306
54. Jones JW, Scott AJ, Tudor G, Xu PT, Jackson IL, Vujaskovic Z, et al. Identification and quantitation of biomarkers for radiation-induced injury via mass spectrometry. Health Phys (2014) 106(1):106-19. doi:10.1097/HP.0b013e3182a4ed3b
55. Ghosh SP, Singh R, Chakraborty K, Kulkarni S, Uppal A, Luo Y, et al. Metabolomic changes in gastrointestinal tissues after whole body radiation in a murine model. Mol Biosyst (2013) 9(4):723-31. doi:10.1039/c3mb25454b
56. Cheema AK, Suman S, Kaur P, Singh R, Fornace AJ Jr, Datta K. Long-term differential changes in mouse intestinal metabolomics after γ and heavy ion radiation exposure. PLoS One (2014) 9(1):e87079. doi:10.1371/journal.pone.0087079
57. He XH, Li WT, Gu YJ, Yang BF, Deng HW, Yu YH, et al. Metabonomic studies of pancreatic cancer response to radiotherapy in a mouse xenograft model using magnetic resonance spectroscopy and principal components analysis. World J Gastroenterol (2013) 19(26):4200-8. doi:10.3748/wjg.v19.i26.4200
58. Johnson CH, Patterson AD, Krausz KW, Kalinich JF, Tyburski JB, Kang DW, et al. Radiation metabolomics. 5. Identification of urinary biomarkers of ionizing radiation exposure in nonhuman primates by mass spectrometry-based metabolomics. Radiat Res (2012) 178(4):328-40. doi:10.1667/RR2950.1
59. Laiakis EC, Mak TD, Anizan S, Amundson SA, Barker CA, Wolden SL, et al. Development of a metabolomic radiation signature in urine from patients undergoing total body irradiation. Radiat Res (2014) 181(4):350-61. doi:10.1667/RR13567.1
60. Sproull M, Kramp T, Tandle A, Shankavaram U, Camphausen K. Serum amyloid A as a biomarker for radiation exposure. Radiat Res (2015) 184(1):14-23. doi:10.1667/RR13927.1
61. Johnson CH, Patterson AD, Krausz KW, Lanz C, Kang DW, Luecke H, et al. Radiation metabolomics. 4. UPLC-ESI-QTOFMS-based metabolomics for urinary biomarker discovery in gamma-irradiated rats. Radiat Res (2011) 175(4):473-84. doi:10.1667/RR2437.1
62. Lanz C, Patterson AD, Slavík J, Krausz KW, Ledermann M, Gonzalez FJ, et al. Radiation metabolomics. 3. Biomarker discovery in the urine of gamma-irradiated rats using a simplified metabolomics protocol of gas-chromatography-mass spectrometry combined with random forests machine learning algorithm. Radiat Res (2009) 172(2):198-212. doi:10.1667/RR1796.1
63. Drucker E, Krapfenbauer K. Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine. EPMA J (2013) 4(1):7. doi:10.1186/1878-5085-4-7
64. Aboud OA, Weiss RH. New opportunities from the cancer metabolome. Clin Chem (2013) 59(1):138-46. doi:10.1373/clinchem.2012.184598
65. Wibom C, Surowiec I, Mörén L, Bergström P, Johansson M, Antti H, et al. Metabolomic patterns in glioblastoma and changes during radiotherapy: a clinical microdialysis study. J Proteome Res (2010) 9(6):2909-19. doi:10.1021/pr901088r
66. Tandle AT, Shankavaram U, Brown MV, Ho J, Graves C, Lita E, et al. Urinary metabolomic profiling of patients with glioblastoma multiforme. J Proteomics Bioinform (2013) S6:003. doi:10.4172/jpb. S6-003
67. Bruggeman FJ, WesterhoffHV. The nature of systems biology. Trends Microbiol (2007) 15(1):45-50. doi:10.1016/j.tim.2006.11.003
68. Hornberg JJ, Bruggeman FJ, WesterhoffHV, Lankelma J. Cancer: a systems biology disease. Biosystems (2006) 83(2-3):81-90. doi:10.1016/j.biosystems.2005.05.014
69. Ideker T, Galitski T, Hood L. A new approach to decoding life: systems biology. Annu Rev Genomics Hum Genet (2001) 2:343-72. doi:10.1146/annurev.genom.2.1.343
70. Unger K. Integrative radiation systems biology. Radiat Oncol (2014) 9:21. doi:10.1186/1748-717X-9-21
71. FDA. Adaptive Design Clinical Trials for Drugs and Biologics. (2017). Available from: http://www.fda.gov/downloads/Drugs/Guidances/ucm201790.pdf
72. Malley MA, O' Dupré J. Fundamental issues in systems biology. Bioessays (2005) 27(12):1270-6. doi:10.1002/bies.20323
73. Chen R, Mias GI, Li-Pook-Than J, Jiang L, Lam HY, Chen R, et al. Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell (2012) 148(6):1293-307. doi:10.1016/j.cell.2012.02.009
74. Boldt S, Knops K, Kriehuber R, Wolkenhauer O. A frequency-based gene selection method to identify robust biomarkers for radiation dose prediction. Int J Radiat Biol (2012) 88(3):267-76. doi:10.3109/09553002.2012.638358
75. Ray M, Yunis R, Chen X, Rocke DM. Comparison of low and high dose ionising radiation using topological analysis of gene coexpression networks. BMC Genomics (2012) 13:190. doi:10.1186/1471-2164-13-190
76. Guipaud O. Serum and plasma proteomics and its possible use as detector and predictor of radiation diseases. Adv Exp Med Biol (2013) 990:61-86. doi:10.1007/978-94-007-5896-4_4
77. Leszczynski D. Radiation proteomics: a brief overview. Proteomics (2014) 14(4-5):481-8. doi:10.1002/pmic.201300390
78. Li-Pook-Than J, Snyder M. iPOP goes the world: integrated personalized omics profiling and the road toward improved health care. Chem Biol (2013) 20(5):660-6. doi:10.1016/j.chembiol.2013.05.001
79. Baverstock K, Nikjoo H. Can a system approach help radiobiology? Radiat Prot Dosimetry (2011) 143(2-4):536-41. doi:10.1093/rpd/ncq467
80. Friedland W, Jacob P, Kundrát P. Mechanistic simulation of radiation damage to DNA and its repair: on the track towards systems radiation biology modelling. Radiat Prot Dosimetry (2011) 143(2-4):542-8. doi:10.1093/rpd/ncq383